News | Infection Update

NEWS

Did the COVID-19 pandemic impact the incidence of life-threatening invasive bacterial infections?

13 September, 2023

In the wake of the unprecedented COVID-19 pandemic, the global healthcare sector has witnessed the profound and ongoing impact of the viral infection on various aspects of public health. One...

In the wake of the unprecedented COVID-19 pandemic, the global healthcare sector has witnessed the profound and ongoing impact of the viral infection on various aspects of public health. One...

Can long-term hospitalisation and antibiotic use for severe COVID-19 pneumonia increase the risk of antimicrobial resistance?

14 August, 2023

COVID-19 infection is known to be associated with a wide range of clinical manifestations, including severe pneumonia. Those affected may exhibit symptoms such as fever, cough, fatigue, and difficulty in...

COVID-19 infection is known to be associated with a wide range of clinical manifestations, including severe pneumonia. Those affected may exhibit symptoms such as fever, cough, fatigue, and difficulty in...

Stabilizing antimicrobial peptides for the treatment of drug-resistant bacterial infections

Given the growing demand for effective antibacterial strategies, researchers are constantly exploring innovative materials and techniques to combat the rise of drug-resistant bacterial pathogens.1 For example, numerous studies have explored...

Given the growing demand for effective antibacterial strategies, researchers are constantly exploring innovative materials and techniques to combat the rise of drug-resistant bacterial pathogens.1 For example, numerous studies have explored...

Can a ‘reverse antibiotic’ combat fluoroquinolone-sensitive and fluoroquinolone-resistant E.coli strains?

The increasing prevalence of antimicrobial resistance is a global healthcare concern;1 evidence suggests that at least 700,000 people worldwide die every year due to antimicrobial resistance.2 Numerous studies have aimed...

The increasing prevalence of antimicrobial resistance is a global healthcare concern;1 evidence suggests that at least 700,000 people worldwide die every year due to antimicrobial resistance.2 Numerous studies have aimed...

To what extent does COVID-19 bacterial co-infection impact clinical outcomes?

COVID-19, caused by the SARS-CoV-2 virus, has resulted in over 6.8 million deaths worldwide.1 Risk factors associated with severe COVID-19 disease symptoms include advanced age, male sex and comorbidities.2 Although...

COVID-19, caused by the SARS-CoV-2 virus, has resulted in over 6.8 million deaths worldwide.1 Risk factors associated with severe COVID-19 disease symptoms include advanced age, male sex and comorbidities.2 Although...

The role of bivalent booster COVID-19 vaccinations in the fight against SARS-CoV-2 Omicron infection

The currently circulating SARS-CoV-2 Omicron BA.1 subvariant consists of more than 30 mutations in the spike protein, of which at least 15 mutations have been identified in the receptor-binding domain,...

The currently circulating SARS-CoV-2 Omicron BA.1 subvariant consists of more than 30 mutations in the spike protein, of which at least 15 mutations have been identified in the receptor-binding domain,...

Immune evasion properties of SARS-CoV-2 Omicron BQ and XBB subvariants – a potential global threat

03 February, 2023

The COVID-19 pandemic remains a significant global concern owing to the emergence of the Omicron variants and its descendant subvariants.1,2,3 Evidence suggests that the increasing prevalence and rapidly expanding spike...

The COVID-19 pandemic remains a significant global concern owing to the emergence of the Omicron variants and its descendant subvariants.1,2,3 Evidence suggests that the increasing prevalence and rapidly expanding spike...

What is the safety profile of a second COVID-19 mRNA vaccine booster?

22 December, 2022

The emergence of SARS-CoV-2 variants of concern (VoCs), and the eventual waning efficacy of the primary vaccination series and first booster dose indicated a need for a second booster dose...

The emergence of SARS-CoV-2 variants of concern (VoCs), and the eventual waning efficacy of the primary vaccination series and first booster dose indicated a need for a second booster dose...

How effective is a recombinant plant-based COVID-19 vaccine?

04 November, 2022

As reported by the World Health Organization, the ongoing COVID-19 pandemic infected more than 608 million people and resulted in 6.5 million deaths worldwide.1 Despite successful deployment of numerous SARS-CoV-2...

As reported by the World Health Organization, the ongoing COVID-19 pandemic infected more than 608 million people and resulted in 6.5 million deaths worldwide.1 Despite successful deployment of numerous SARS-CoV-2...

Can maternal vaccination protect infants against COVID-19 related hospitalization?

13 September, 2022

The risk of severe illness and hospitalization associated with COVID-19 is reportedly higher in infants who are 6 months of age or younger;1,2 however, no vaccines are currently authorized for...

The risk of severe illness and hospitalization associated with COVID-19 is reportedly higher in infants who are 6 months of age or younger;1,2 however, no vaccines are currently authorized for...

LATEST TOPICS